Exact Sciences Corporation provided revenue guidance for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company expects total revenue between $550.7 million and $552.7 million, an increase of 16%, or 28% excluding COVID-19 testing.
For the full year, the company expects total revenue between $2,082.0 million and $2,084.0 million, an increase of 18%, or 25% excluding COVID-19 testing.